Portugal, April 1 -- Portugal based GILEAD SCIENCES has secured contract from Unidade Local De Saude De Amadora/Sintra, Epe for Acquisition Of Lenacapavir Sc 464Mg1.5Ml Sol Inj (Aue 202501290) From Lab Gilead To Ulsasi For The Year 2026. The value of the contract is worth 4417600 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....